Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by VancouverPigon Oct 26, 2017 5:31pm

106 Views

Post# 26865255

The sad news is

HV only owns 5,951,250 common shares. Of which 1,000,000 were bought with this PP.

How does that equate to Management support over all these years? Unless the CEO used this pump and dump to circulate shares for profit when ever he could. I would have thought he would have as many or more than Geraldine.

What this company needs is credible management to move ahead. Vote the Pracks out on the 18th.

signed: VancouverPig that is voting NO on the 18th.

Bullboard Posts

Changing Europe’s dependency on HREE from China